Jonathan Freve Insider Profile
4 Followers
Jonathan Freve, CFO at Damora Therapeutics, holds 12.00K shares in Damora Therapeutics (Ticker: DMRA), holds 17.48K shares in F-star Therapeutics (Ticker: FSTX). Most recently, Jonathan Freve Bought ― shares of Damora Therapeutics on Dec 06, 2021 for an estimated value of $9.96K.
Jonathan Freve's Trading History
| DMRADamora Therapeutics | Dec 06, 2021 | CFO | Informative Buy | 9.96K | $284.40K | |
| FSTXF-star Therapeutics | Nov 14, 2019 | ― | Informative Buy | 15.20K | $124.47K |
You May Also Like
Jonathan Freve insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Freve?
The percentage of profitable transactions made by Jonathan Freve is 0%.
What is the average return per transaction made by Jonathan Freve?
The average return per transaction made by Jonathan Freve is -56.70%.
What stocks does Jonathan Freve hold?
Jonathan Freve holds: DMRA, FSTX stocks.
What was Jonathan Freve’s latest transaction?
Jonathan Freve’s latest transaction was an Informative Buy of $9.96K.
What was Jonathan Freve's most profitable transaction?
Jonathan Freve’s most profitable transaction was an Informative Buy of DMRA stock on December 6, 2021. The return on the trade was -44.60%.
What is Jonathan Freve's role in Damora Therapeutics?
Jonathan Freve's role in Damora Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
